Skip to main content
Fig. 1 | Orphanet Journal of Rare Diseases

Fig. 1

From: Nintedanib in idiopathic and secondary pleuroparenchymal fibroelastosis

Fig. 1

Spaghetti plot representing the evolution of FVC (% of predicted) in 9 patients with PPFE before and on nintedanib treatment. The “0” point and the dotted vertical line represent the initiation of nintedanib. All patients experienced sustained FVC (% of predicted) decline before nintedanib. FVC decline was slowed or stabilized during nintedanib treatment in 8 patients

Back to article page

Orphanet Journal of Rare Diseases

ISSN: 1750-1172